TUMOR TARGETING WITH L-ENANTIOMERIC OLIGONUCLEOTIDE CONJUGATES OF IMMUNOREAGENTS AND OF CHELATED RADIONUCLIDES - Patent 0691981

(19)

(11)

EP 0 691 981 A1

(12)

(43)	Date of publication:
	17.01.1996 Bulletin 1996/03

(21)	Application number: 94911542.0

(22)	Date of filing: 10.03.1994

(51)

International Patent Classification (IPC):

G01N 33/ 574^{( . )}
A61K 51/ 00^{( . )}
C07H 21/ 00^{( . )}

A61K 39/ 395^{( . )}
A61K 51/ 10^{( . )}
C07K 16/ 00^{( . )}

(86)	International application number:
	PCT/US1994/002610

(87)	International publication number:
	WO 1994/020523 (15.09.1994 Gazette 1994/21)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

10.03.1993 US 19930033083

(71)	Applicant: THE WELLCOME FOUNDATION LIMITED
	London NW1 2BP (GB)

(72)	Inventors:
	SNOW, Robert Allen West Chester, PA 19380 (US) BLACK, Christopher Douglas Valiant Silver Spring, MD 20906 (US)

(74)	Representative: Baker-Munton, Nicola Jane, et al
	The Wellcome Foundation Limited Langley Court Beckenham Kent BR3 3BS Beckenham Kent BR3 3BS (GB)

(54)	TUMOR TARGETING WITH L-ENANTIOMERIC OLIGONUCLEOTIDE CONJUGATES OF IMMUNOREAGENTS AND OF CHELATED RADIONUCLIDES